Role of Budesonide in Corona Virus Disease: Systematic Review

Main Article Content

Dr. Bala Yadu Vamsi Sankuratri, Dr. Rahul V. C. Tiwari, Dr. Aarushi Shekhar, Dr. Abhimanyu Singh, Dr. Ajith Babu Poovathingal, Dr. Mylesh Ravisankar Dakshinamurthy, Dr. Heena Tiwari

Abstract

Background: The current COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, raises important questions as to whether pre-morbid use or continued administration of inhaled corticosteroids (ICS) affects the outcomes of acute respiratory infections due to coronavirus.


Purpose of study:Inhaled budesonide is a low cost, safe (time censored), effective (number needed to treat of eight) simple  and widely available therapeutic option, which can be of great help around the world, particularly in low-income and middle-income countries. Several potential mechanisms might underlie these clinical observations.


Results: Inhaled budesonide in early Covid-19 infection significantly reduced the likelihood of requiring urgent care, emergency department consultation and hospitalization.


Conclusion: The budesonide group reported greater wellbeing of the patients. Also scales down the need for urgent medical care and reduces recovery time, if given early to Covid-19 patients with mild symptoms.

Article Details

How to Cite
Dr. Bala Yadu Vamsi Sankuratri, Dr. Rahul V. C. Tiwari, Dr. Aarushi Shekhar, Dr. Abhimanyu Singh, Dr. Ajith Babu Poovathingal, Dr. Mylesh Ravisankar Dakshinamurthy, Dr. Heena Tiwari. (2021). Role of Budesonide in Corona Virus Disease: Systematic Review. Annals of the Romanian Society for Cell Biology, 25(6), 4902–4907. Retrieved from https://annalsofrscb.ro/index.php/journal/article/view/6351
Section
Articles